Gyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Cash & Equivalents	33.51	25.18	44.35	30.36	15.37	31.26	19.81	29.73	63.02	1.87	Upgrade
Short-Term Investments	0	0	2.5	48.99	61.5	88.91	17.97	6.8	3.4	0	Upgrade
Cash & Cash Equivalents	33.51	25.18	46.85	79.35	76.87	120.18	37.78	36.53	66.43	1.87	Upgrade
Cash Growth	33.10%	-46.27%	-40.96%	3.24%	-36.04%	218.13%	3.41%	-45.00%	3448.34%	-97.97%	Upgrade
Receivables	21.56	17.14	1.82	3.31	15	0	0	0.03	0.49	0.1	Upgrade
Inventory	4.28	6.12	0	0	0	0	0	0	0	0	Upgrade
Other Current Assets	-2.13	1.22	2.81	6.84	4.2	3.81	1.33	0.96	1.78	0.1	Upgrade
Total Current Assets	57.22	49.65	51.48	89.51	96.07	123.99	39.11	37.52	68.7	2.07	Upgrade
Property, Plant & Equipment	23.78	18.38	3.71	2.27	2.23	0.39	0.28	0.44	0.7	0.91	Upgrade
Long-Term Investments	23.43	7.39	0	2.54	0	0	0	0	0	0	Upgrade
Goodwill and Intangibles	1.7	1.86	0	0	0	0	0	0	0	0	Upgrade
Other Long-Term Assets	10.41	7.48	0.47	0.53	0.26	0.54	0.13	0.13	0.13	0	Upgrade
Total Long-Term Assets	59.32	35.1	4.19	5.34	2.49	0.93	0.4	0.57	0.82	0.91	Upgrade
Total Assets	116.54	84.75	55.66	94.85	98.55	124.92	39.51	38.09	69.52	2.98	Upgrade
Accounts Payable	1.72	0.24	6.42	5.93	4.28	1.25	0.75	0.84	0.94	0.25	Upgrade
Deferred Revenue	0.25	0.26	0.23	1.98	15	0	0.21	0.33	0.73	2.48	Upgrade
Current Debt	0.21	0.49	1.98	0.66	0.48	0	5.09	19.4	33.74	0	Upgrade
Other Current Liabilities	17.86	11.25	5.54	9.22	9.14	3.55	2.7	1.4	2.34	-0.39	Upgrade
Total Current Liabilities	20.05	12.24	14.17	17.8	28.9	4.8	8.74	21.97	37.76	2.34	Upgrade
Long-Term Debt	0.2	0.12	0.41	0.98	1.32	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	17.82	0.17	0	0	0	0.17	0	0.05	0.34	1.12	Upgrade
Total Long-Term Liabilities	18.02	0.29	0.41	0.98	1.32	0.17	0	0.05	0.34	1.12	Upgrade
Total Liabilities	38.07	12.54	14.57	18.78	30.22	4.98	8.74	22.02	38.1	3.46	Upgrade
Total Debt	0.41	0.61	2.39	1.64	1.8	0	5.09	19.4	33.74	0	Upgrade
Debt Growth	-33.28%	-74.30%	45.07%	-8.77%	-	-	-73.79%	-42.50%	-	-	Upgrade
Retained Earnings	-85.54	7.4	-402.69	-314.76	-258.52	-203.34	-173.49	-147.98	-131.04	-116.28	Upgrade
Comprehensive Income	-1.64	-0.39	0	0.01	0.03	-0	0	-0	0	0	Upgrade
Shareholders' Equity	-15.83	42.52	41.09	76.07	68.34	119.95	30.77	16.07	31.43	-109.35	Upgrade
Net Cash / Debt	33.1	24.56	44.47	77.71	75.06	120.18	32.69	17.13	32.68	1.87	Upgrade
Net Cash / Debt Growth	34.76%	-44.76%	-42.78%	3.53%	-37.54%	267.61%	90.85%	-47.59%	1645.83%	-97.95%	Upgrade
Net Cash Per Share	0.50	0.32	21.77	60.78	93.79	160.75	143.22	329.76	1660.25	1145.65	Upgrade
Working Capital	37.17	37.41	37.31	71.71	67.17	119.19	30.37	15.56	30.94	-0.27	Upgrade
Book Value Per Share	-0.24	0.67	20.11	59.49	85.39	160.44	134.82	309.39	1596.41	-66934.52	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).